It all starts with a vision. To take on the prevailing norms and confront them with the psyche of transforming the world. To perceive what is ethically valid and change the lives of countless. Of course, if you are at an honored position in your life, then it becomes more than easy to achieve.
The same happened with this story’s protagonist. He perceived the industry like none other and envisioned to provide better services than their counterparts. He did not seek opportunities to maximize profits. Instead, he led a company that delivers maximum to society.
We would like to introduce Aegis Lifesciences and its CEO, Mr. Rajeev Gupta.
Mr. Gupta was a Class I Indian Government Officer. While he is an exceptional entrepreneur today, he also bears the virtue of being a gold medalist engineer. Alongside, he is also ranked in Indian Engineering Services (IES).
During his services to the Indian Government, he came across an issue. Big MNCs were topping on profits in the manufacturing of Absorbable Hemostats. The prices touched the sky with only availability to top-end hospitals and expensive surgeries. At minimal, the slightest penetration was to 2-tier city’s hospitals.
Perceiving it as an opportunity, he challenged the principal industry players. He took on the manufacturers producing the same product at an economical price. Thereby bringing the change to small hospitals, reducing the hospitalization cost. This also assisted patients to recover fast without bleeding complications during surgeries.
Today, under his leadership, Aegis has a customer base across 50+ countries. It enjoys the largest pie of market share and is growing at CAGR of 30% annually.
The Name of the Game
Establishment in 2008, in Ahmedabad, Aegis Lifesciences is one of the world’s leading manufacturer & exporter of Absorbable Hemostatic Gelatin Sponges. It leads the industry with its own brand name SURGISPON® and OEM for brands such as Bausch + Lomb, etc.
Aegis offers products across the globe, including the most quality-conscious markets. Its flagship product, SURGISPON® is registered and distributed in almost entire EU (European Union), NHS-UK, CIS, Central America, Russia, LATAM, MENA, South Africa, South East Asia regions, amongst others.
The most promising fact about the firm is its ability to reach the zenith of success in few years. Not to mention, the base of its operations relies on international quality standards along with the state-of-the-art in-house manufacturing facilities. Aegis also enjoys the certification as ISO:13485 and the GMP standards of many countries.
Aegis Lifesciences has gained international certificates of CE (Class III medical devices) & ISO: 13485 Quality Assurance System both from DNV GL Nemko Presafe AS, Norway.
Also, being truly customer-centric in thought and action, Aegis believes that customization and quality is the key for creating and retaining a sturdy customer base. The USP of AEGIS has always been: it offers BEST products at the BEST prices.
“We lead the industry with the ideology of ‘Technology has a meaning when it is available and affordable to common man’”
Meet the Flagship Product
SURGISPON® Absorbable Hemostatic Gelatin Sponge is a quick and effective hemostat. It stops bleeding fast and reduces intra operative bleeding and surgery time.
The manufacturing process of SURGISPON® is tailored, customized, simplified, and indigenous. Hence, it leads to cost-effective treatment compared to its competitors across the globe.
More than that, the firm not only innovates the mechanical processes but also creates differentiation in critical manufacturing techniques. An example of such include packaging & sterilization process resulting in a better quality product at an affordable price.
Aegis has carried similar innovation forward in novel products such as Surgi-ORC (Oxidized Regenerated Cellulose) and Surgi-PVA (PVA sponges) as an extension of hemostatic products range.
A Global Grip
Aegis has a firm grip over the world via key five areas:
Its geography is best suited for products where acceptance and awareness of the product benefits, such as India, the European Union, the US, Central America, South East Asia, Russia.
The firm is in partnership with the strong distributor of the target area which has a wider reach to the target customers i.e. surgeons.
Aegis’s firm belief in the finest of certifications and related documentation as regulatory is one of the key criteria for entry into the target area. Hence, it operates with CE2460 and ISO:13485, with MDSAP certifications coming soon.
Its dedicated teams handle both local and global marketing for creating market plans and managing sales with local distributors.
Global registration and exclusive distributorship agreement in 50+ countries and growing continuously.
Society’s Care for Tomorrow
Regarding Aegis’s future aspects, Mr. Gupta cites that there is no better time to realize the future of the healthcare industry than the present pandemic time. It is pretty clear now for humankind that the next big need across the globe is to prioritize and work on their healthcare segment.
He says, “We at Aegis are gearing up with innovating in every aspect, be it technology or infrastructure. From the product technology perspective, we are challenging ourselves to bring best in class locally manufactured products not only in the current hemostat segment but other ailments too.
“Similarly, we are improvising on infrastructure for mass production and capacity building to reduce cost and to increase the reach of our products to every corner of the society,” he concluded.